Claims for Patent: 11,110,151

✉ Email this page to a colleague

Summary for Patent: 11,110,151

Title:	Composition and method for reducing hypoglycemia events in diabetes treatment
Abstract:	An ultra-rapid acting insulin composition and method for treating hyperglycemia in patients with diabetes are disclose. The composition is an inhalable dry powder composition comprising fumaryl diketopiperazine and insulin for pulmonary delivery, which significantly reduces the rates of hypoglycemic events in patients in patients on mealtime insulin therapy.
Inventor(s):	Marshall Grant, Simon R. Bruce, Robert A. Baughman
Assignee:	Mannkind Corp
Application Number:	US16/449,308
Patent Claims:

Details for Patent 11,110,151

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	June 07, 2000	11,110,151	2039-06-21
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	January 19, 2001	11,110,151	2039-06-21
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	April 23, 2004	11,110,151	2039-06-21
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	October 31, 2013	11,110,151	2039-06-21
Sanofi-aventis U.s. Llc	LANTUS	insulin glargine	Injection	021081	April 20, 2000	11,110,151	2039-06-21
Sanofi-aventis U.s. Llc	LANTUS	insulin glargine	Injection	021081	April 25, 2007	11,110,151	2039-06-21
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.